Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive study scans hearts of 4,000 arthritis patients to uncover hidden risks

NCT ID NCT07363980

First seen Jan 23, 2026 · Last updated Jun 21, 2026 · Updated 26 times

Summary

This study follows 4,000 people with rheumatoid arthritis (ages 50-75) over 10 years to better understand their risk for heart disease, lung problems, and mental health issues like depression and anxiety. Participants get a special heart CT scan, lung function tests, and provide blood samples for genetic and protein analysis. The goal is to improve early detection and prevention of these common complications in rheumatoid arthritis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Aarhus University Hospital

    Aarhus, Denmark

  • Esbjerg Hospital

    Esbjerg, Denmark

  • Regional Hospital Gødstrup

    Herning, Denmark

  • Silkeborg Regional Hospital

    Herning, Denmark

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could lead to better ways to identify and manage heart, lung, and mental health problems in people with rheumatoid arthritis.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly test any new therapy. Results may take years and might not change current care.

Conditions

The condition(s) this trial relates to.

anxiety disorder atherosclerotic cardiovascular disease cardiovascular disorder chronic obstructive pulmonary disease COPD, severe early onset depressive disorder disease ischemic disease lung cancer lung disorder lung neoplasm Respiration Disorders rheumatoid arthritis rheumatoid arthritis-associated interstitial lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.